Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
Changhai Lei(Second Military Medical University), Shi Hu(Second Military Medical University), Wenyan Fu(Beijing Biocytogen (China)), Min Ding(Jiangsu University), Li Tian(Sichuan University), Sheng Zhang(Shanghai East Hospital), Kewen Qian(Shanghai Medical College of Fudan University)
Cited by 432
Related Papers
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
|Nature Communications|2019|484
Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid
|Journal of Biological Chemistry|2005|388
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study
|Annals of Intensive Care|2020|146
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
|The Lancet Regional Health - Western Pacific|2023|112
Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig
|bioRxiv (Cold Spring Harbor Laboratory)|2020|94